Figure 5 | Scientific Reports

Figure 5

From: A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications

Figure 5

Meta-analysis for all the studies on fluvoxamine treatment of COVID-19 and clinical deterioration sub-grouped by dose. (A) Forrest plot. High dose LogOR 0.6957 (95% CI 0.3777 to 1.0137) z = 4.2882, p < 0.0001. Low dose LogOR 1.198 (95% CI -0.930 to 3.325) z = 1.082, p = 0.279. (B) Funnel Plot. No Asymmetry was observed at either high or low dose grouping.

Back to article page